References

Global prevalence of diabetes-related neuropathy and vascular complications: a systematic review and meta-analysis

10.1016/j.diabres.2026.113103 · 2026 · External reference

Diabetic neuropathy: a position statement by the American Diabetes Association

10.2337/dc16-2042 · 2017 · External reference

Advances in screening, early diagnosis and accurate staging of diabetic neuropathy

10.3389/fendo.2021.671257 · 2021 · External reference

Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults: a prospective cohort study

10.7326/m20-1340 · 2021 · External reference

Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy

10.1007/s12020-024-03954-6 · 2024 · External reference

Using corneal confocal microscopy to compare Mecobalamin intramuscular injections vs oral tablets in treating diabetic peripheral neuropathy: a RCT

10.1038/s41598-021-94284-4 · 2021 · External reference

Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach

10.3389/fendo.2024.1380929 · 2024 · External reference

Effectiveness of current diagnostic methods in the early detection of diabetic peripheral neuropathy: are we missing the window

10.7759/cureus.106429 · 2026 · External reference

Better diagnostic accuracy of neuropathy in obesity: a new challenge for neurologists

10.1016/j.clinph.2018.01.003 · 2018 · External reference

Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments

10.1016/s1474-4422(22)00188-0 · 2022 · External reference

Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention

10.1016/s2213-8587(19)30081-6 · 2019 · External reference

Feasibility and effectiveness of electrochemical dermal conductance measurement for the screening of diabetic neuropathy in primary care. Decoding study (Dermal Electrochemical Conductance in Diabetic Neuropathy)

10.3390/jcm8050598 · 2019 · External reference

Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy

10.1007/s00125-022-05846-8 · 2023 · External reference

Serum neurofilament light chain - a potential biomarker for polyneuropathy in type 2 diabetes

10.1016/j.diabres.2023.110988 · 2023 · External reference

Diabetic neuropathy: cutting-edge research and future directions

10.1038/s41392-025-02175-1 · 2025 · External reference

Mini-review on insulin resistance assessment: advances in surrogate indices and clinical applications

10.12998/wjcc.v13.i29.108380 · 2025 · External reference

The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux

10.1172/jci77812 · 2016 · External reference

Diabetic peripheral neuropathy: current epidemiology, diagnostic advances, biomarkers, and management strategies

10.1155/jdr/9080699 · 2026 · External reference

Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms

10.1097/j.pain.0000000000001922 · 2020 · External reference

The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp

10.1210/jc.2010-0288 · 2010 · External reference

Triglyceride-glucose index is a useful marker for predicting future cardiovascular disease and mortality in young Korean adults: a nationwide population-based cohort study

10.12997/jla.2022.11.2.178 · 2022 · External reference

Assessment of triglyceride–glucose index and ratio in patients with type 2 diabetes and their relation to microvascular complications

10.1080/07435800.2023.2245909 · 2023 · External reference

The clinical significance of PLR, NLR, SII, TyG, and TyG-BMI in peripheral neuropathy among patients with newly diagnosed T2DM

10.12056/j.issn.1006-2785.2024.46.23.2023-1297 · 2024 · External reference

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

10.1136/bmj.n160 · 2021 · External reference

The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects

10.1089/met.2008.0034 · 2008 · External reference

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

10.2337/diacare.17.11.1281 · 1994 · External reference

Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy

10.2337/diacare.25.11.2048 · 2002 · External reference

Retinopathy, neuropathy, and foot care: standards of care in diabetes-2025

10.2337/dc25-s012 · 2025 · External reference

Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

10.1212/01.wnl.0000149522.32823.ea · 2005 · External reference

Joint European Academy of Neurology-European Pain Federation-Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment

10.1111/ene.15831 · 2023 · External reference

Chinese guidelines for the prevention and treatment of type 2 diabetes (2020 edition) (part 2)

10.19538/j.nk2021090106 · 2021 · External reference

AHRQ's evidence-based practice centres prove viable. Agency for Healthcare Research and Quality

10.1016/s0140-6736(05)72963-9 · 2000 · External reference

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

10.1007/s10654-010-9491-z · 2010 · External reference

Calculation of sensitivity and specificity from partial data for meta-analyses: introducing some practical methods

10.22037/aaemj.v13i1.2678 · 2025 · External reference

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

10.1186/1471-2288-14-135 · 2014 · External reference

Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range

10.1177/0962280216669183 · 2018 · External reference

Prognostic value of triglyceride-derived metabolic parameters for micro- and macrovascular complications and mortality in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study

10.1111/dme.70263 · 2026 · External reference

Impact of baseline and trajectory of the cardiometabolic indices on incident microvascular complications in patients with type 2 diabetes

10.1016/j.atherosclerosis.2025.120407 · 2025 · External reference

Triglyceride-glucose index, genetic susceptibility, and trajectory of microvascular multimorbidity in type 2 diabetes

10.1038/s41598-026-39777-w · 2026 · External reference

Triglyceride glucose index predicts long-term mortality and major adverse cardiovascular events in patients with type 2 diabetes

10.1186/s12933-025-02671-2 · 2025 · External reference

Correlation of triglyceride-glucose index and the presence of microvascular complications of diabetes

10.7759/cureus.90363 · 2025 · External reference

Triglyceride glucose index for the detection of diabetic kidney disease and diabetic peripheral neuropathy in hospitalized patients with type 2 diabetes

10.1007/s13300-024-01609-3 · 2024 · External reference

The association of triglyceride-glucose index and neutrophil-to-lymphocyte ratio with type 2 diabetic peripheral neuropathy

2025 · External reference

The correlation between TyG index and diabetic peripheral neuropathy

10.3969/j.issn.2096-305x.2025.03.010 · 2025 · External reference

The predictive value of different insulin resistance indices and blood pressure variability for peripheral neuropathy in patients with hypertension and diabetes

2025 · External reference

The predictive value of the triglyceride-glucose index for type 2 diabetes with peripheral neuropathy

2022 · External reference

Correlation between triglyceride-glucose index and diabetic vascular complications

10.3969/j.issn.1006-6187.2023.02.005 · 2023 · External reference

Correlation of serum UA/HDL-C ratio and TyG index with peripheral neuropathy in elderly patients with type 2 diabetes mellitus and their predictive value

2026 · External reference

Potential molecular biomarkers for predicting and monitoring complications in type 2 diabetes mellitus

10.3390/molecules30224448 · 2025 · External reference

A role for insulin in diabetic neuropathy

10.3389/fnins.2016.00581 · 2016 · External reference

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

10.2337/diacare.14.3.173 · 1991 · External reference

Sarcopenia and chronic complications of type 2 diabetes mellitus

10.1900/rds.2022.18.157 · 2022 · External reference

Adipose tissue content, muscle performance and physical function in obese adults with type 2 diabetes mellitus and peripheral neuropathy

10.1016/j.jdiacomp.2014.11.003 · 2015 · External reference

The vicious cycle of type 2 diabetes mellitus and skeletal muscle atrophy: Clinical, biochemical, and nutritional bases

10.3390/nu16010172 · 2024 · External reference

The role of insulin resistance in diabetic neuropathy in Koreans with type 2 diabetes mellitus: a 6-year follow-up study

10.3349/ymj.2014.55.3.700 · 2014 · External reference

Analysis of factors related to type 2 diabetic peripheral neuropathy based on flash glucose monitoring system

10.12659/msm.939157 · 2023 · External reference

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man

10.1007/bf00280883 · 1985 · External reference

High dietary fat consumption impairs axonal mitochondrial function in vivo

10.1523/jneurosci.1852-20.2021 · 2021 · External reference

New horizons in diabetic neuropathy: Mechanisms, bioenergetics, and pain

10.1016/j.neuron.2017.02.005 · 2017 · External reference

Association between triglyceride-glucose index and diabetic retinopathy: A meta-analysis

10.1055/a-2279-7112 · 2024 · External reference

Triglyceride glucose index and the risk of diabetic nephropathy in patients with type 2 diabetes: A meta-analysis

10.1055/a-2376-6044 · 2025 · External reference

The triglyceride paradox in people of African descent

10.1089/met.2011.0108 · 2012 · External reference

Association between the triglyceride-glucose index and risk of type 2 diabetes mellitus and the mediating effect of BMI: a comparative analysis in Chinese and Japanese populations

10.3389/fendo.2026.1701371 · 2026 · External reference

Metabolic obesity in people with normal body weight (MONW)-Review of diagnostic criteria

10.3390/ijerph19020624 · 2022 · External reference

The normal-weight type 2 diabetes phenotype revisited

10.1016/j.dsx.2016.01.035 · 2016 · External reference

The triglycerides and glucose index is more strongly associated with metabolically healthy obesity phenotype than the lipid and obesity indices

10.1007/s40618-023-02201-5 · 2024 · External reference

Lean diabetes is one end of the spectrum of type 2 diabetes and not a separate entity

10.1016/j.diabres.2025.112387 · 2025 · External reference

Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study

10.1016/s2213-8587(19)30187-1 · 2019 · External reference

Insulin resistance versus insulin deficiency: evidence of racial differences in the pathogenesis of type 2 diabetes

10.1136/bmjdrc-2021-002261 · 2021 · External reference

Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

10.1097/cm9.0000000000003034 · 2024 · External reference

Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)

10.1002/dmrr.3266 · 2020 · External reference

Variability in the clinical diagnosis of diabetic peripheral neuropathy

10.1016/j.pcd.2019.05.008 · 2020 · External reference

Predictors of peripheral neuropathy among persons with diabetes mellitus: a multicenter cross-sectional study

10.7547/l22-053 · 2025 · External reference

Prevalence and determinants of complications of type 2 diabetes in a community screening program in Kerala

10.1136/bmjph-2024-002333 · 2025 · External reference

Are inflammatory markers important for assessing the severity of diabetic polyneuropathy

10.3390/medicina61030400 · 2025 · External reference

Investigation of the relationship between the triglyceride-glucose index and metabolic and hematological parameters in obese individuals

10.55730/1300-0144.6019 · 2025 · External reference

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study

10.2147/dmso.s65500 · 2014 · External reference

Statins and peripheral neuropathy in diabetic and non-diabetic cases: a systematic review

10.1093/jpp/rgac104 · 2023 · External reference

Dapagliflozin ameliorate type-2 diabetes associated neuropathy via regulation of IGF-1R signaling

10.1007/s11481-025-10200-x · 2025 · External reference

Association of the triglyceride glucose index and its related indices with coronary artery disease risk: mediation by glycated haemoglobin

10.3389/fendo.2026.1809007 · 2026 · External reference

The association between TyG index and cardiovascular mortality is modified by antidiabetic or lipid-lowering agent: a prospective cohort study

10.1186/s12933-025-02620-z · 2025 · External reference

Overadjustment bias and unnecessary adjustment in epidemiologic studies

10.1097/ede.0b013e3181a819a1 · 2009 · External reference